Boston Scientific Corp.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
54.85%
Market Cap
61.06 Bil.
P/E Ratio
49.17
Dividend Yield
0.00 %
Earnings per Share
1.72 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 94.91 Bil. | 31.13 Bil. | 23.29 | +27.43 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 41.08 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:47 PM | |
| DAILY VOLUME (UNITS) | 2 | |
| DAILY HIGH / LOW | 41.305 | 40.75 |
| PREV. DAY'S PRICE | 40.995 | (06/02) |
| CHANGE DAY BEFORE | +0.09 | 0.21 % |
| 52 WEEK HIGH / LOW | 93.8 (07/31) | 40.78 (06/01) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 3.21 | 2.89 | 1.72 | 1.15 | 0.99 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 13.10 | 14.57 | 49.17 | 71.62 | 53.89 |
| PRICE - BOOK RATIO | - | - | 5.84 | 6.05 | 4.39 |
| PRICE - SALES RATIO | - | - | 7.10 | 7.93 | 5.94 |
| PRICE - CASH FLOW RATIO | - | - | 31.43 | 38.64 | 33.80 |
Master Data
| WKN | 884113 |
| ISIN | US1011371077 |
| SYMBOL | BSX |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Boston Scientific |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 1.49 Bil. |
| MARKET CAPITALISATION | 61.06 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -17.37 % | -16.49 % | -37.12 % | -52.00 % | -54.85 % | -15.11 % | 20.43 % | -49.76 % |
| HIGH | 49.56 | 50.09 | 65.80 | 86.60 | 93.80 | 103.00 | 103.00 | 86.60 |
| LOW | 40.78 | 40.78 | 40.78 | 40.78 | 40.78 | 40.78 | 33.30 | 40.78 |
Dividend
per share
Boston Scientific does not deliver dividend information
Company profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Structured products for Boston Scientific Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.